Shanshan Zhang
State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk.
Journal: Nature
Published: July 14, 2025
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 02, 2022
EBV-Upregulated B7-H3 Inhibits NK cell-Mediated Antitumor Function and Contributes to Nasopharyngeal Carcinoma Progression.
Journal: Cancer immunology research
Published: May 10, 2022
A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo.
Journal: Journal of virology
Published: March 29, 2022
EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation.
Journal: Cancer research
Published: July 14, 2021
mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma.
Journal: Cancer research
Published: January 24, 2021
A comprehensive risk score for effective risk stratification and screening of nasopharyngeal carcinoma.
Journal: Nature communications
Published: April 06, 2020
Beyond regulation of pol III: Role of MAF1 in growth, metabolism, aging and cancer.
Journal: Biochimica et biophysica acta. Gene regulatory mechanisms
Published: September 16, 2017
Prognostic Value of MicroRNA-125 in Various Human Malignant Neoplasms: a Meta-Analysis.
Journal: Clinical laboratory
Published: January 07, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026